Everyone is asking how Ronaldo does it – at 41, he looks and performs like a player in his twenties. Part of the answer lies in a bottle of supplements tailored specifically to his body, based on blood tests and biological markers. And now, this technology is about to become accessible to many more people.
Herbalife has recently announced that it is acquiring the assets of Bioniq – a British company founded in London in 2019 that specializes in personalized nutritional supplements based on blood tests and personal questionnaires. Bioniq’s technology builds a unique biological profile for each user and matches it with a precise nutrition plan – far removed from the old “one vitamin C pill fits all” approach.
Ronaldo, a long-time partner of Herbalife and a shareholder in Bioniq, does not hide his appreciation for the technology: “I have personally experienced how tracking individual markers and tailoring nutrition can support performance at the highest level,” he said. “I’m happy to see Bioniq’s solutions becoming part of Herbalife and enabling people to make more informed decisions about their health.”
For Herbalife, which has been operating since 1980 in more than 90 countries, this marks a significant strategic step into the world of technology and personal data. “We are creating a personalized wellness experience that combines science with human connection,” said CEO Stephan Gratziani. The deal is expected to close in the second quarter of 2026, and Bioniq’s supplements will become available later this year in Europe and the United States – and subsequently in additional markets.
The trend is also being felt in Israel. “We are seeing a rise in awareness of the importance of personalization in nutrition and wellness,” said Ron Porat, CEO of Herbalife Israel. In an era where everyone tracks their sleep, steps, and heart rate – the next step is clear: Nutrition, too, is becoming fully personalized.